Zeta Corporation Precision Recombinant Antibodies

New Released Products

November 2024

Catalog Updated

August 24,2024

Lung Cancer Product Focus

December 2024

NEW PRODUCT FOCUS

Spring 2024

MMR related antibodies

DNA mismatch repair (MMR) system

Welcome Dr. Cheri Walker

Recombinant Antibodies

Zeta develops highly specific and sensitive primary recombinant antibodies for immunohistochemistry suitable for routine and differential diagnosis in anatomic pathology laboratories. Recombinant antibodies provide the highest performance, reproducibility, and rapid manufacturing for consistant, reliable results. Zeta offers a large portfolio of recombinant antibodies including 400+ tumor and tissue specific IVD recombinant antibodies for immunohistochemistry.

MonoMAb™ Antibodies

MonoMAb™ mouse monoclonal antibodies are uniquely developed monospecific antibodies where high performing clones are screened using a high throughput protein chip to select the most specific one. Finally, they are sequenced and engineered for recombinant production providing the most rapid, reliable and reproducible manufacturing. Zeta offers a large portfolio of recombinant antibodies including 400+ tumor and tissue specific IVD recombinant antibodies for immunohistochemistry.

RAbMono™ Antibodies

RAbMono™ rabbit monoclonal antibodies are uniquely produced and target-validated for IHC on FFPE tissue sections. They stand out because of their superior specificity, low background, and high affinity. Finally, they are sequenced and engineered for recombinant production providing the most rapid, reliable and reproducible manufacturing. Zeta offers a large portfolio of recombinant antibodies including 400+ tumor and tissue specific IVD recombinant antibodies for immunohistochemistry.

About
Corporation

Zeta Corporation is leader in IVD precision recombinant antibodies for immunohistochemistry. Zeta is an ISO 13485:2016 and FDA registered biomedical company that manufactures and distributes IVD antibodies for Pathology/IHC. We provide the highest quality of antibodies to help pathologists diagnose human tumors and diseases. Zeta antibodies are carefully curated to provide reproducible results on formalin-fixed, paraffin-embedded (FFPE) sections manually or using commercially available automated equipment. Zeta utilizes its collective knowledge of over 75 years to validate and standardize every antibody individually for immunohistochemistry (IHC) application.

We are proud of our commitment to producing highly specific, target-validated, and characterized IVD primary biomarkers to aid pathologists in the differential diagnosis of various tumors.

Zeta Corporation sells the products directly in the US and distributes them to over 50 different countries globally through our trusted partners.

Learn more about Zeta Corporation

About Corporation

About
Corporation